BioCryst Pharmaceuticals, Inc. (BCRX) vs Perrigo Company plc (PRGO)
- BioCryst Pharmaceuticals, Inc. BCRX 7.79 −2.87%
- Perrigo Company plc PRGO 16.63 +0.91%
BioCryst Pharmaceuticals, Inc. and Perrigo Company plc are both Drug Manufacturers Specialty & Generic companies. Perrigo Company plc is the larger, with a market value of $2.3B against $2.1B — 1.1× the size. BioCryst Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 68.7% against −4.19%. BioCryst Pharmaceuticals, Inc. has the higher net margin (−40.9% vs −41.9%) and the lower return on invested capital (−610.6% vs −18.1%). Across the 18 metrics below, BioCryst Pharmaceuticals, Inc. leads on 12 and Perrigo Company plc on 6.
Valuation
Profitability
| Metric | BCRX | PRGO | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 97.78% | 33.26% | 53.94% |
| Operating margin | (33.29%) | (37.71%) | 0.00% |
| Net margin | (40.90%) | (41.85%) | 0.00% |
| Free cash flow margin | 39.75% | 2.88% | 0.00% |
| Return on equity | 87.84% | (49.65%) | (0.40%) |
| Return on assets | (75.79%) | (19.60%) | (3.32%) |
| Return on invested capital | (610.55%) | (18.06%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack